[Myocardial contrast echocardiography from peripheral venous injection: the potential for detection of myocardial...

Area of Science:

• Cardiology
• Medical Imaging
• Echocardiography

Background:

• Myocardial contrast echocardiography (MCE) is valuable for assessing myocardial perfusion abnormalities in ischemic heart disease.
• Traditional MCE requires direct intracoronary injection of contrast agents, limiting patient selection and accessibility.
• Existing microbubble contrast agents (e.g., Albunex) have limitations in persistence and require invasive administration.

Purpose of the Study:

• To evaluate novel echo contrast agents for myocardial opacification via intravenous injection.
• To assess the safety and efficacy of these new agents in myocardial perfusion imaging.
• To explore the potential of noninvasive MCE for evaluating myocardial infarction.

Main Methods:

• Development of novel echo contrast agents: perfluorocarbon gas-filled microbubbles coated with stabilizing surfactants.
• Administration of contrast agents via intravenous injection.
• Evaluation of myocardial opacification, agent persistence, and hemodynamic/cardiopulmonary effects in animal and human studies.

Main Results:

• Novel echo contrast agents demonstrate potential for myocardial opacification after intravenous injection.
• These agents exhibit longer persistence compared to air-filled microbubbles.
• Studies in animals and humans report high efficacy, safety, and no significant adverse hemodynamic or cardiopulmonary effects.

Conclusions:

• Intravenous echo contrast agents offer a promising noninvasive approach for myocardial perfusion assessment.
• This advancement could significantly improve the evaluation of myocardial infarction before and after therapeutic interventions.
• Future applications include reliable, noninvasive assessment of myocardial perfusion in clinical settings.